The effects of iron and desferrioxamine on the lung injury induced by intravenous bleomycin and hyperoxia
- PMID: 2468585
- DOI: 10.3109/10715768709088095
The effects of iron and desferrioxamine on the lung injury induced by intravenous bleomycin and hyperoxia
Abstract
The development of acute lung injury in rats following the intravenous injection of bleomycin was assessed by measuring the total pulmonary extravascular albumin space. Intravenous bleomycin alone produced no evidence of lung injury, yet when combined with a simultaneous exposure to hyperoxia or simultaneous tracheal instillation of ferric iron or ascorbate a severe lung injury evolved. Neither ferric iron or ascorbate alone produced lung injury when assessed in this manner, and ferrous iron, ferritin and haemoglobin did not potentiate bleomycin induced lung injury. A continuous subcutaneous infusion of desferrioxamine enhanced hyperoxia induced lung injury, and had no modulating effect on the lung injury produced by combined intravenous bleomycin and hyperoxia. These results indicate that ferric iron can potentiate bleomycin induced lung injury, and that the metal chelator desferrioxamine can have adverse effects on the development of acute lung injury.
Similar articles
-
Mechanisms of bleomycin-induced lung damage.Arch Toxicol. 1991;65(2):81-94. doi: 10.1007/BF02034932. Arch Toxicol. 1991. PMID: 1711838 Review.
-
Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats.Thorax. 1987 May;42(5):374-82. doi: 10.1136/thx.42.5.374. Thorax. 1987. PMID: 2443992 Free PMC article.
-
Differences in effects of immediate and delayed hyperoxia exposure on bleomycin-induced pulmonary injury.Cancer Treat Rep. 1984 May;68(5):759-64. Cancer Treat Rep. 1984. PMID: 6202406
-
Modulation of the development of bleomycin-induced fibrosis by deferoxamine.Toxicol Appl Pharmacol. 1988 Mar 15;92(3):358-67. doi: 10.1016/0041-008x(88)90176-7. Toxicol Appl Pharmacol. 1988. PMID: 2451318
-
Potentiating effects of oxygen in lungs damaged by methylcyclopentadienyl manganese tricarbonyl, cadmium chloride, oleic acid, and antitumor drugs.Toxicol Appl Pharmacol. 1983 Jan;67(1):55-69. doi: 10.1016/0041-008x(83)90244-2. Toxicol Appl Pharmacol. 1983. PMID: 6189266
Cited by
-
Deferoxamine (desferrioxamine). New toxicities for an old drug.Drug Saf. 1991 Jan-Feb;6(1):37-46. doi: 10.2165/00002018-199106010-00004. Drug Saf. 1991. PMID: 2029352 Review.
-
Mechanisms of bleomycin-induced lung damage.Arch Toxicol. 1991;65(2):81-94. doi: 10.1007/BF02034932. Arch Toxicol. 1991. PMID: 1711838 Review.
-
The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.Antioxid Redox Signal. 2019 Nov 1;31(13):954-993. doi: 10.1089/ars.2019.7818. Epub 2019 Jul 11. Antioxid Redox Signal. 2019. PMID: 31184204 Free PMC article. Review.
-
Iron metabolism in the lower respiratory tract.Thorax. 1998 Jul;53(7):594-600. doi: 10.1136/thx.53.7.594. Thorax. 1998. PMID: 9797761 Free PMC article. Review. No abstract available.
-
Smoking-induced iron dysregulation in the lung.Free Radic Biol Med. 2019 Mar;133:238-247. doi: 10.1016/j.freeradbiomed.2018.07.024. Epub 2018 Jul 31. Free Radic Biol Med. 2019. PMID: 30075191 Free PMC article. Review.